1 / 55

CASE CONFERENCE

CASE CONFERENCE. Ang, Kevin Aningalan , Arvin Antonio, Aby Aramburo , Jan Cruel, Anna. General Data. J.R. 1 yr and 11 mos , Female Santa Cruz, Manila Filipino, Roman Catholic Informant: Mother Reliability: good. History of Present Illness. 6 weeks PTC.

oral
Download Presentation

CASE CONFERENCE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CASE CONFERENCE Ang, Kevin Aningalan, Arvin Antonio, Aby Aramburo, Jan Cruel, Anna

  2. General Data • J.R. • 1 yr and 11 mos, Female • Santa Cruz, Manila • Filipino, Roman Catholic • Informant: Mother • Reliability: good

  3. History of Present Illness 6 weeks PTC • Mother palpated multiple movable, firm, non-tender masses over lateral aspects of neck • No other symptoms noted • No consult was done

  4. History of Present Illness 2 weeks PTC • Patient experienced intermittent low-grade fever (37.8°C), occurring at night time, not relieved by intake of Paracetamol • No accompanying symptoms • no anorexia • no weight loss • no cough • no colds • no medications given no consult done

  5. History of Present Illness 8 days PTC • Patient experienced cough and colds with clear discharge • (-) anorexia • (-) weight loss • (-) difficulty of breathing

  6. History of Present Illness 5 days PTC • Patient sought consult at OPD • (+) boggy turbinates • (+) multiple cervical lymphadenopathy, movable, firm, non-tender over lateral aspects of neck • Assessment: to r/o PTB • Plans: PPD, CXR, to follow-up with results

  7. History of Present Illness Consult • PPD test: 10mm • Chest X-Ray PA and Lateral: suggestive of Primary Koch’s

  8. Review of Systems (-) weight loss, (-)anorexia (-) itchiness, pigmentation, rash, active dermatoses (-) blurring of vision, redness, itchiness, Iacrimation (-) deafness, tinnitus, aural discharge (-) anosmia, epistaxis, sinusitis, nasal discharge (-) bleeding gums, oral sores, tonsillitis (-) neck mass, neck stiffness, limitation of motion (-) chest pain, nocturnal dyspnea, palpitation, syncope, edema (-) phlebitis, varicosities, claudication (-) dysphagia, nausea, vomiting, retching, hematemesis, melena, hematochezia, belching, indigestion, diarrhea, constipation (-) urinary frequency, urgency, hesitancy, dysuria, hematuria, nocturia (-) joint stiffness, joint pain, muscle pain, cramps (-) heat-cold intolerance, polydipsia, polyphagia, polyuria (-) headache, depression, seizures

  9. Past Medical History No Previous Surgeries Past Medical Illnesses • Acute pyelonephritis (January 2009) • Acute rhinitis (February 2009) • Acute nasopharyngitis, probably viral (September 2009) Immunizations: complete Hepa B1,2,3 Hib 1,2,3 MMR DPT 1,2,3 booster BCG OPV 1,2,3 booster Measles Allergies: none

  10. Family History (+) Hypertension – mother (+) DM – grandfather (+) PTB – uncle who stays at home with patient (-) Cardiovascular diseases, stroke

  11. Family Profile

  12. Gestational and Birth History • Patient born to a 31 y/o G2P1 unemployed housewife married to a 34 y/o seaman • With regular prenatal check-up since 7 weeks AOG. • Denied illnesses during the entire pregnancy • Outcome was live term singleton female delivered via NSD AS 8,9 MT 38-39 wks AGA BW 3.01 BL 47 HC 33.5 CC 31.5 AC 30. • No complications

  13. Socioeconomic and Environmental History

  14. Physical Examination General Survey: Awake, alert, not in cardiorespiratory distress, well-nourished, well-hydrated Vital Signs:HR 90bpm RR 20cpm T 36.7oC Anthropometric Data: 82.5cm (Z score above 0) Weight:15kg (Z score above 0) HC: 48 cm WFL: above zero Skin: Warm moist skin, no rashes, no jaundice, no active dermatosis Head: Normocephalic, pink palpebral conjunctiva, anicteric sclera, isochoric pupils, midline septum, no alar flaring, (+) nasoauraldischarge, turbinates congested, no oral ulcers, moist buccal mucosa, non-hyperemic pharyngeal wall, tonsils not enlarged, no aural pits or tags, no tragal tenderness, nonhyperemic EAC, intact TM, AU

  15. Physical Examination Adynamicprecordium, apex beat at 4th LICS, MCL, no lifts, no heaves, no thrills, S1>S2 at the apex, S2>S1 at the base, (-) S3, (-) murmurs Supple neck, (+) multiple cervical lymphadenopathies, trachea at midline Symmetrical chest expansion, no barrel chest, no supraclavicular retractions, clear breath sounds, (-) wheezes, (-) crackles Abdomen flabby, no scars, normoactive bowel sounds, tympanitic all over, no direct or rebound tenderness, no masses

  16. Salient Features

  17. Approach to Diagnosis

  18. Presenting Manifestation • 2 week history of intermittent low grade fever (37.8 C), occurring at night time • 8 day history of cough and colds • (+) multiple cervical lymphadenopathies • Exposure to PTB • PPD test: 10mm • Chest X-Ray PA and Lateral: suggestive of Koch’s infection

  19. Approach to Diagnosis • A presenting manifestation pointing to the least number of diseases • Fever + Cervical Lymphadenopathy • PTB • Group A Strep Pharyngitis • Lymphoma • Kawasaki disease

  20. Primary Tuberculosis Infection • Epidemiology: TB is endemic in the Philippines • The majority of children with tuberculosis infection develop no signs or symptoms at any time. • Non-specific signs & symptoms

  21. Signs and Symptoms • Cough of more than 2 weeks duration • Fever of more than 2 weeks duration • Painless cervical and/or other lymphadenopathies • Poor weight gain • Failure to make a quick return to normal health after infection • Failure to respond to appropriate antibiotics

  22. Tuberculin Skin test • Screening test of high risk individuals • Used to determine • Latent TB infection • Infected persons • Measure of a person’s cellular immune responsiveness

  23. Interpretation • ≥ 5mm • Non BCG vaccinated • < 5 years old • ≥ 10mm • BCG vaccinated • < 5 years old with positive exposure • ≥ 15mm • > 5 years old with or without BCG

  24. Tuberculosis Disease At least 3 of the following: • (+) exposure to PTB • (+) TST • Clinical signs and symptoms of PTB • Radiographic Findings of PTB

  25. Assessment • Pulmonary Tuberculosis Disease

  26. Tuberculin Skin Test Induration of 10 mm or more is considered a positive TST result in the following children: • Children who are at a higher risk of dissemination of tuberculous disease, including those younger than 5 years or those who are immunosuppressed because of conditions such as lymphoma, Hodgkin disease, diabetes mellitus, and malnutrition • Children with increased exposure to the disease, including those who are exposed to adults in high-risk categories (eg, homeless, HIV infected, users of illicit drugs, residents of nursing homes, incarcerated or institutionalized persons); those who were born in or whose parents were born in high-prevalence areas of the world; and those with travel histories to high-prevalence areas of the world

  27. Treatment Plans Curative: • Isoniazid 200mg/5ml, 1.5 ml (5mg/kg/d) OD • Rifampicin 200mg/5ml, 3 ml (10mg/kg/d) OD • Pyrazinamide 250mg/5ml, 3.5 ml (15mg/kg/d) OD • Streptomycin 1g/2ml, 0.5 ml IM (22mg/kg/d) OD • Refer to DOTS • Refer to ENT

  28. Treatment Plans • Supportive • Multivitamins • Dietary advice given

  29. Preventive • Advise the patient to strictly comply and complete the regimen • Anticipatory guidelines • Follow-up on vaccination • Avoid overcrowded and unsanitary areas

  30. Follow up after 2 weeks

  31. First Line Anti-TB drugs • Isoniazid(H) • Rifampicin(R) • Pyrazinamide(Z) • Streptomycin(S) • Ethambutol(E)

  32. Treatment • a 6-month course of isoniazid (INH) and rifampin, supplemented during the first 2 months with pyrazinamide. • Because poor adherence to these regimens is a common cause of treatment failure, directly observed therapy (DOT) is recommended for treatment of tuberculosis.

  33. Treatment

  34. Treatment

  35. Brief discussion of the diagnosis

  36. Tuberculosis • Mycobacterium tuberculosis is the most important cause of tuberculosis disease in humans. • Other causes include: M. bovis, M. africanum, M. microti, M. Canetti.

  37. Latent Tuberculosis infection • Occurs after inhalation of infective droplet nuclei containing Mycobacterium tuberculosis. • Reactive tuberculin skin test (TST) and absence of clinical and radiographic manifestation are the hallmark of this stage • Disease occurs when signs and symptoms and radiographic changes become apparent • Untreated LTB have up to 40% likelihood of developing TB in children.

  38. Transmission • Person to person • By airborne mucus droplet 4-5um in diameter • Increased when patient has positive AFB smear, extensive upper lobe infection/cavity, copious production of thin sputum and severe and forceful cough • Young children rarely infect others because tubercle bacilli are sparse in the endobronchial secretions of children with PTB and cough is often absent or lack tussive force required to suspend infectious particles for transmission.

  39. Pathogenesis • Primary complex includes local infection at the portal of entry and the regional lymph nodes that drain the area • Tubercle bacilli multiply initially within the alveoli and alveolar ducts, most of the bacilli are killed, but some survive within nonactivated macrophages, which carry them through lymphatic vessels to the regional lymph nodes.

  40. Tissue reaction in the lung parenchyma and lymph nodes intensifies over the next 2-12 weeks. • The parenchymal portion of the primary complex often heals completely by fibrosis or calcification after undergoing caseous necrosis and encapsulation.

  41. Tuberculin Skin Testing (TST) • The development of delayed type hypersensitivity reaction in most individuals infected with tubercle bacillus makes the TST a useful diagnostic tool. • The Mantoux Tuberculin Skin Test is the intradermal injection of 0.1mL containing 5 tuberculin units of purified protein derivative (PPD. • T cells sensitized by prior infection are recruited to the skin where they release lymphokines that induce induration through local vasodilatation, edema, fibrin depositon and recruitment of other inflammatory cells to the area.

  42. TST should be read by a trained person 48-72 hours after administration. • Occasional patients will have the induration >72 hours after placement, this is also a positive result. • Immediate hypersensitivity reaction are shortlived (<24 hours) and are not considered a positive result.

  43. Tuberculin sensitivity develops 3 weeks to 3 months after inhalation of organism • Factors that can depress skin test reaction: • Very young age • Malnutrition • Immunosuppresion • Viral infection • Vaccines with live virus • Overwhelming tuberculosis

  44. False positive reaction to TST can be caused by cross sensitization to antigens on non tuberculousmycobacteria • Previous BCG (Especially if 2 doses of BCG are already given) • In general, a > or equal to 10mm in a BCG vaccinated child indicates infection

  45. Tuberculin Skin Test • Induration of 5 mm or more is considered a positive TST result in the following children: • Children having close contact with known or suspected contagious cases of the disease, including those with household contacts with active tuberculosis whose treatment cannot be verified before exposure • Children with immunosuppressive conditions (eg, HIV) or children who are on immunosuppressive medications • Children who have an abnormal chest radiography finding consistent with active tuberculosis, previously active tuberculosis, or clinical evidence of the disease

  46. Tuberculin Skin Test Induration of 10 mm or more is considered a positive TST result in the following children: • Children who are at a higher risk of dissemination of tuberculous disease, including those younger than 5 years or those who are immunosuppressed because of conditions such as lymphoma, Hodgkin disease, diabetes mellitus, and malnutrition • Children with increased exposure to the disease, including those who are exposed to adults in high-risk categories (eg, homeless, HIV infected, users of illicit drugs, residents of nursing homes, incarcerated or institutionalized persons); those who were born in or whose parents were born in high-prevalence areas of the world; and those with travel histories to high-prevalence areas of the world

  47. Tuberculin Skin Test • Induration of 15 mm or more is considered a positive TST result in children aged 5 years or older without any risk factors for the disease

  48. Clinical Manifestations • Majority develop no signs or symptoms • Occasionaly, with low grade fever and mild cough • Rarely with high fever, cough, malaise and flu like symptoms.

  49. Primary Pulmonary Disease • Primary complex includes parenchymal pulmonary focus and regional lymph nodes • Initial parenchymal inflammation is usually not visible on chest radiograph • Hallmark of primary tuberculosis in the lungs is the relatively large size of regional lymphadenitis compared with the relatively small size of the intial lung focus

More Related